These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28492394)

  • 1. Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
    Seng R; Ghislain M; Girard PM; Cotte L; Meybeck A; Raffi F; Abgrall S; Yazdanpanah Y; Goujard C; Dray-Spira R; Meyer L
    AIDS; 2017 Jun; 31(9):1323-1332. PubMed ID: 28492394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
    de Monteynard LA; Matheron S; Gilquin J; Pavie J; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Simon A; Mahamat A; Dray-Spira R; Costagliola D; Abgrall S;
    AIDS; 2016 Sep; 30(14):2235-46. PubMed ID: 27428741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
    de Monteynard LA; Dray-Spira R; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Gilquin J; Rey D; Simon A; Pavie J; Mahamat A; Matheron S; Costagliola D; Abgrall S;
    PLoS One; 2015; 10(3):e0118492. PubMed ID: 25734445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
    Gatey C; Brun A; Hamet G; Diamantis S; Sellier P; Bouchaud O; Garrait V; Rozenbaum W; Molina JM; Abgrall S;
    HIV Med; 2019 Feb; 20(2):175-181. PubMed ID: 30506853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    AIDS; 2017 Mar; 31(6):835-846. PubMed ID: 28272136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.
    de Monteynard LA; Matheron S; Grabar S; de Truchis P; Gilquin J; Pavie J; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Mahamat A; Dray-Spira R; Simon A; Costagliola D; Abgrall S;
    PLoS One; 2018; 13(10):e0205385. PubMed ID: 30379870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    HIV Med; 2018 Jan; 19(1):42-48. PubMed ID: 28741837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.
    Pistone T; Ouattara E; Gabillard D; Lele N; Duvignaud A; Cordel H; Malvy D; Bouchaud O; Abgrall S;
    Travel Med Infect Dis; 2019; 29():40-47. PubMed ID: 30951905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
    AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
    Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
    AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study, France, 2011.
    Maraux B; Hamelin C; Bajos N; Dray-Spira R; Spire B; Lert F;
    Contraception; 2015 Aug; 92(2):160-9. PubMed ID: 25940932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care-a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999-2013.
    Zeitlmann N; Gunsenheimer-Bartmeyer B; Santos-Hövener C; Kollan C; An der Heiden M;
    BMC Infect Dis; 2016 Dec; 16(1):739. PubMed ID: 27927190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in interleukin-7 receptor α gene is associated with faster CD4⁺ T-cell recovery after initiation of combination antiretroviral therapy.
    Hartling HJ; Thørner LW; Erikstrup C; Harritshøj LH; Kronborg G; Pedersen C; Larsen CS; Helleberg M; Gerstoft J; Obel N; Ullum H; Nielsen SD
    AIDS; 2014 Jul; 28(12):1739-48. PubMed ID: 24911352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Country of birth does not influence long-term clinical, virologic, and immunological outcome of HIV-infected children living in the Netherlands: a cohort study comparing children born in the Netherlands with children born in Sub-Saharan Africa.
    Cohen S; van Bilsen WP; Smit C; Fraaij PL; Warris A; Kuijpers TW; Geelen SP; Wolfs TF; Scherpbier HJ; van Rossum AM; Pajkrt D
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):178-85. PubMed ID: 25405830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
    Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J;
    AIDS; 2015 Nov; 29(17):2323-33. PubMed ID: 26544704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.
    Abgrall S; Raho-Moussa M; Seng R; Ghislain M; Matheron S; Pialoux G; Goujard C; Meyer L;
    Antivir Ther; 2019; 24(7):541-552. PubMed ID: 31868654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.
    Pantazis N; Papastamopoulos V; Paparizos V; Metallidis S; Adamis G; Antoniadou A; Psichogiou M; Chini M; Sambatakou H; Sipsas NV; Gogos C; Chrysos G; Panagopoulos P; Katsarou O; Gikas A; Touloumi G;
    AIDS; 2019 Aug; 33(10):1645-1655. PubMed ID: 31305332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.
    Monge S; Alejos B; Dronda F; Del Romero J; Iribarren JA; Pulido F; Rubio R; Miró JM; Gutierrez F; Del Amo J;
    HIV Med; 2013 May; 14(5):273-83. PubMed ID: 23171059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy.
    Guzmán-Fulgencio M; Berenguer J; Micheloud D; Fernández-Rodríguez A; García-Álvarez M; Jiménez-Sousa MA; Bellón JM; Campos Y; Cosín J; Aldámiz-Echevarría T; Catalán P; López JC; Resino S
    J Antimicrob Chemother; 2013 Oct; 68(10):2349-57. PubMed ID: 23749950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan, Italy.
    Ridolfo AL; Oreni L; Vassalini P; Resnati C; Bozzi G; Milazzo L; Antinori S; Rusconi S; Galli M
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):315-321. PubMed ID: 28418991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.